Spots Global Cancer Trial Database for spiegelmer
Every month we try and update this database with for spiegelmer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Olaptesed (NOX-A12) Alone and in Combination With Pembrolizumab in Colorectal and Pancreatic Cancer | NCT03168139 | Metastatic Colo... Metastatic Panc... | Olaptesed pegol... Olaptesed pegol... | 18 Years - | TME Pharma AG | |
Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients | NCT04121455 | Glioblastoma | Olaptesed pegol Radiotherapy Bevacizumab Pembrolizumab | 18 Years - | TME Pharma AG | |
Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients | NCT04121455 | Glioblastoma | Olaptesed pegol Radiotherapy Bevacizumab Pembrolizumab | 18 Years - | TME Pharma AG | |
Olaptesed (NOX-A12) Alone and in Combination With Pembrolizumab in Colorectal and Pancreatic Cancer | NCT03168139 | Metastatic Colo... Metastatic Panc... | Olaptesed pegol... Olaptesed pegol... | 18 Years - | TME Pharma AG | |
NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL) | NCT01486797 | Chronic Lymphoc... | NOX-A12 | 18 Years - | TME Pharma AG |